Expression of Costimulatory Ligand CD70 on Steady-State Dendritic Cells Breaks CD8+ T Cell Tolerance and Permits Effective Immunity

Immunity

Volumn 29, Issue 6, 2008, Pages 934-946

  Keller, Anna M ^a   Schildknecht, Anita ^b   Xiao, Yanling ^a   van den Broek, Maries ^b   Borst, Jannie ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

ADJUVANT; CD27 ANTIGEN; CD70 ANTIGEN; EPITOPE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD70; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; MELANOMA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS; OVALBUMIN; PEPTIDE FRAGMENTS;

EID: 57449091055     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.10.009     Document Type: Article

References (50)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94-96
2. Arens R., Tesselaar K., Baars P.A., van Schijndel G.M., Hendriks J., Pals S.T., Krimpenfort P., Borst J., van Oers M.H., and van Lier R.A. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 15 (2001) 801-812
3. + T cell formation. J. Exp. Med. 199 (2004) 1595-1605
4. Arens R., Nolte M.A., Tesselaar K., Heemskerk B., Reedquist K.A., van Lier R.A., and van Oers M.H. Signaling through CD70 regulates B cell activation and IgG production. J. Immunol. 173 (2004) 3901-3908
5. Arens R., Baars P.A., Jak M., Tesselaar K., van der Valk M., van Oers M.H., and van Lier R.A. Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation. J. Immunol. 174 (2005) 5915-5920
6. Barber D.L., Wherry E.J., and Ahmed R. Cutting edge: Rapid in vivo killing by memory CD8 T cells. J. Immunol. 171 (2003) 27-31
7. Battegay M., Cooper S., Althage A., Banziger J., Hengartner H., and Zinkernagel R.M. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33 (1991) 191-198
8. + T-cell response. Nat. Rev. Immunol. 4 (2004) 595-602
9. Bloom M.B., Perry-Lalley D., Robbins P.F., Li Y., El-Gamil M., Rosenberg S.A., and Yang J.C. Identification of Tyrosinase-related Protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185 (1997) 453-459
10. Borst J., Hendriks J., and Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17 (2005) 275-281
11. Brocker T., Riedinger M., and Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185 (1997) 541-550
12. + T cells. J. Immunol. 174 (2005) 710-717
13. de Witte M.A., Coccoris M., Wolkers M.C., van den Boom M.D., Mesman E.M., Song J.Y., van der Valk M., Haanen J.B., and Schumacher T.N. Targeting self-antigens through allogeneic TCR gene transfer. Blood 108 (2006) 870-877
14. Diehl L., den Boer A.T., Schoenberger S.P., van der Voort E.I., Schumacher T.N., Melief C.J., Offringa R., and Toes R.E. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med. 5 (1999) 774-779
15. Garcia P., de Heredia A.B., Bellon T., Carpio E., Llano M., Caparros E., Aparicio P., and Lopez-Botet M. Signalling via CD70, a member of the TNF family, regulates T cell functions. J. Leukoc. Biol. 76 (2004) 263-270
16. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.N., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 (2001) 769-779
17. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., and Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1 (2000) 433-440
18. Hendriks J., Xiao Y., and Borst J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198 (2003) 1369-1380
19. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., and Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
20. Huleatt J.W., and Lefrancois L. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J. Immunol. 154 (1995) 5684-5693
21. + dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17 (2002) 211-220
22. Kearney E.R., Pape K.A., Loh D.Y., and Jenkins M.K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1 (1994) 327-339
23. Keller A.M., Groothuis T.A., Veraar E.A., Marsman M., Maillette de Buy Wenniger L., Janssen H., Neefjes J., and Borst J. Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules. Proc. Natl. Acad. Sci. USA 104 (2007) 5989-5994
24. Kurts C., Cannarile M., Klebba I., and Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166 (2001) 1439-1442
25. Laouar Y., Sutterwala F.S., Gorelik L., and Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6 (2005) 600-607
26. Lee W.W., Yang Z.Z., Li G., Weyand C.M., and Goronzy J.J. Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis. J. Immunol. 179 (2007) 2609-2615
27. Marzo A.L., Klonowski K.D., Le Bon A., Borrow P., Tough D.F., and Lefrancois L. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6 (2005) 793-799
28. Muranski P., Boni A., Antony P.A., Cassard L., Irvine K.R., Kaiser A., Paulos C.M., Palmer D.C., Touloukian C.E., Ptak K., et al. Tumor-specific Th17-polarized cells eradicate large established melanomas. Blood 112 (2008) 362-373
29. + mouse spleen dendritic cells do not originate from the CD8alpha- dendritic cell subset. Blood 102 (2003) 601-604
30. Ochsenbein A.F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., and Zinkernagel R.M. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 411 (2001) 1058-1064
31. Overwijk W.W., Theoret M.R., Finkelstein S.E., Surman D.R., de Jong L.A., Vyth-Dreese F.A., Dellemijn T.A., Antony P.A., Spiess P.J., Palmer D.C., et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J. Exp. Med. 198 (2003) 569-580
32. Pircher H., Moskophidis D., Rohrer U., Bürki K., Hengartner H., and Zinkernagel R.M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346 (1990) 629-633
33. Probst H.C., Langel J., Kollias G., and van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18 (2003) 713-720
34. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6 (2005) 280-286
35. Redmond W.L., and Sherman L.A. Peripheral tolerance of CD8 T lymphocytes. Immunity 22 (2005) 275-284
36. Rolink A., Melchers F., and Andersson J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5 (1996) 319-330
37. Rowley T.F., and Al-Shamkhani A. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. J. Immunol. 172 (2004) 6039-6046
38. Sanchez P.J., McWilliams J.A., Haluszczak C., Yagita H., and Kedl R.M. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 178 (2007) 1564-1572
39. Sawalha A.H., and Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. Eur. J. Immunol. 37 (2007) 1407-1413
40. Schildknecht A., Miescher I., Yagita H., and van den Broek M. Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells. Eur. J. Immunol. 37 (2007) 716-728
41. Shortman K., and Liu Y. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
42. Soares H., Waechter H., Glaichenhaus N., Mougneau E., Yagita H., Mizenina O., Dudziak D., Nussenzweig M.C., and Steinman R.M. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204 (2007) 1095-1106
43. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21 (2003) 685-711
44. Taraban V.Y., Rowley T.F., and Al-Shamkhani A. Cutting edge: A critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J. Immunol. 173 (2004) 6542-6546
45. Tesselaar K., Gravestein L.A., van Schijndel G.M., Borst J., and van Lier R.A. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159 (1997) 4959-4965
46. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M.W., Schuurhuis D.H., Mebius R., Borst J., and van Lier R.A.W. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170 (2003) 33-40
47. Tesselaar K., Arens R., van Schijndel G.M., Baars P.A., van der Valk M.A., Borst J., van Oers M.H., and van Lier R.A. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Nat. Immunol. 4 (2003) 49-54
48. Warger T., Osterloh P., Rechtseiner G., Fassbender M., Heib V., Schmid B., Schmitt E., Schild H., and Radsak M.P. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108 (2006) 544-550
49. Watts T.H. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23 (2005) 23-68
50. Yamada A., Salama A.D., Sho M., Najafian N., Ito T., Forman J., Kewalramani R., Sandner S., Harada H., Clarckson M.R., et al. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J. Immunol. 174 (2005) 1357-1364